EDCTP Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2019
NCT04437836
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

EDCTP

Active Ingredients

Drugs in Phase 2 Trials (2)

remdesivir (Veklury) (1 trial)

rifampin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

HIV Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2